Abiraterone Viasana

Medicinal product

(Invented) name

Abiraterone Viasana

Active substance (s)

Abiraterono acetatas

Strength

500 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02BX03, Abiraterone

Marketing authorisation holder

UAB Viasana, Lietuva

Date of authorisation

2021-12-07

Date of renewal

Documents

4864 Abiraterone Viasana II PL 2023 12 04.docx

LT_H_0157_001_DC_PAR summary&LT apzvalga.pdf

4864 Pakuotės lapelis 2023 12 04.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LT/H/0157/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Abiraterono acetatas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107712	93817	1093817	lizdinė plokštelė	N56		Receptinis	LT/1/21/4864/001	Netiekiama	-	-	No	-	-
107713	93818	1093818	lizdinė plokštelė	N60		Receptinis	LT/1/21/4864/002	Netiekiama	2024-11-14	-	No	-	-

Stadijos

Data	Stadija
2025-04-30	Išregistruotas
2021-12-07	Registruotas